Efficacy and Safety of Once‐Weekly and Once‐Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta‐Analysis of Clinical Trials

Documenti analoghi

• Simplified Switching to Once‐Weekly Insulin Icodec Without an Initial One‐Time Additional Dose Versus Once‐Daily Insulin Glargine U100 in Basal Insulin‐Treated Type 2 Diabetes ( ONWARDS 10): A Randomised Controlled Trial
  di: Julio Rosenstock, et al.
  Pubblicazione: (2026)
• Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
  di: Obieda Altobaishat, et al.
  Pubblicazione: (2025)
• Efficacy, Safety and PK of Once‐Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model‐Informed Drug Development Approach
  di: Rune Viig Overgaard, et al.
  Pubblicazione: (2026)
• Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed‐Dose Titration of Weekly Insulin Efsitora in Insulin‐Naïve Type 2 Diabetes
  di: Lisa Connery, et al.
  Pubblicazione: (2026)
• Cardiorenal Safety and Efficacy of Sotagliflozin: A Stratified Meta‐Analysis by Diabetes Type and Dosage
  di: Junlei Liao, et al.
  Pubblicazione: (2026)